<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65234</article-id><article-id pub-id-type="doi">10.7554/eLife.65234</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>A non-genetic, cell cycle dependent mechanism of platinum resistance in lung adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-164128"><name><surname>Gonzalez Rajal</surname><given-names>Alvaro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216845"><name><surname>Marzec</surname><given-names>Kamila A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164130"><name><surname>McCloy</surname><given-names>Rachael A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106788"><name><surname>Nobis</surname><given-names>Max</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1861-1390</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164136"><name><surname>Chin</surname><given-names>Venessa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164127"><name><surname>Hastings</surname><given-names>Jordan F</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216846"><name><surname>Lai</surname><given-names>Kaitao</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216847"><name><surname>Kennerson</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237011"><name><surname>Hughes</surname><given-names>William E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216848"><name><surname>Vaghjiani</surname><given-names>Vijesh</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97287"><name><surname>Timpson</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216850"><name><surname>Cain</surname><given-names>Jason E</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-216851"><name><surname>Watkins</surname><given-names>D Neil</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-163845"><name><surname>Croucher</surname><given-names>David R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4965-8674</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-22024"><name><surname>Burgess</surname><given-names>Andrew</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4536-9226</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">The Kinghorn Cancer Centre</institution>, <institution>Garvan Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff2"><institution content-type="dept">ANZAC Research Insitute</institution>, <institution>University of Sydney</institution>, <addr-line><named-content content-type="city">Concord</named-content></addr-line>, <country>Australia</country></aff><aff id="aff3"><institution content-type="dept">Cancer Division</institution>, <institution>Garvan Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff4"><institution>Children's Medical Research Institute</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff5"><institution content-type="dept">Centre for Cancer Research</institution>, <institution>Hudson Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Clayton</named-content></addr-line>, <country>Australia</country></aff><aff id="aff6"><institution content-type="dept">CancerCare Manitoba</institution>, <institution>Research Institute in Oncology and Hematology</institution>, <addr-line><named-content content-type="city">Winnipeg</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-33764"><name><surname>Murphy</surname><given-names>Maureen E</given-names></name><role>Reviewing editor</role><aff><institution>The Wistar Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.rajal@garvan.org.au</email> (AG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>d.croucher@garvan.org.au</email> (DC);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>andrew.burgess@sydney.edu.au</email> (AB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>05</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e65234</elocation-id><history><date date-type="received"><day>01</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Gonzalez Rajal et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Gonzalez Rajal et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65234-v1.pdf"/><abstract><p>We previously used a pulse-based <italic>in vitro </italic>assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single cell fates both <italic>in vitro </italic>and <italic>in vivo,</italic> we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001026</institution-id><institution>National Breast Cancer Foundation</institution></institution-wrap></funding-source><award-id>IIRS-18-103</award-id><principal-award-recipient><name><surname>Burgess</surname><given-names>Andrew</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Tour de Cure</institution></institution-wrap></funding-source><award-id>RSP-230-2020</award-id><principal-award-recipient><name><surname>Burgess</surname><given-names>Andrew</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001171</institution-id><institution>Cancer Institute NSW</institution></institution-wrap></funding-source><award-id>10/FRL/3-02</award-id><principal-award-recipient><name><surname>Burgess</surname><given-names>Andrew</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001171</institution-id><institution>Cancer Institute NSW</institution></institution-wrap></funding-source><award-id>2013/FRL102</award-id><principal-award-recipient><name><surname>Croucher</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001171</institution-id><institution>Cancer Institute NSW</institution></institution-wrap></funding-source><award-id>15/REG/1-17</award-id><principal-award-recipient><name><surname>Croucher</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were carried out in compliance with the Australian code for the care and use of animals for scientific purposes and in compliance with Garvan Institute of Medical Research/St. Vincent's Hospital Animal Ethics Committee guidelines (ARA_18_17, ARA_16_13).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Raw RNAseq data has been uploaded to the NCBI Gene Expression Omnibus (GEO) data repository with the accession number GSE161800.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Burgess A</collab><collab>Gonzalez-Rajal A</collab><collab>Lai K</collab></person-group><year iso-8601-date="2020">2020</year><source>Pulsed cisplatin treatment of A549 lung adenocarcinoma cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161800">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161800</ext-link><comment>NCBI Gene Expression Omnibus, GSE161800</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-65234-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>